nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—PPARG—stomach cancer	0.229	0.427	CbGaD
Rosiglitazone—CYP2A6—stomach cancer	0.221	0.412	CbGaD
Rosiglitazone—ALB—stomach cancer	0.0862	0.161	CbGaD
Rosiglitazone—SLCO1B1—Irinotecan—stomach cancer	0.0498	0.187	CbGbCtD
Rosiglitazone—CYP2A6—Fluorouracil—stomach cancer	0.041	0.154	CbGbCtD
Rosiglitazone—ALB—Irinotecan—stomach cancer	0.0273	0.102	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—stomach cancer	0.0264	0.099	CbGbCtD
Rosiglitazone—ALB—Fluorouracil—stomach cancer	0.0262	0.0983	CbGbCtD
Rosiglitazone—CYP2C9—Capecitabine—stomach cancer	0.0238	0.0894	CbGbCtD
Rosiglitazone—CYP2C8—Fluorouracil—stomach cancer	0.0202	0.076	CbGbCtD
Rosiglitazone—CYP1A2—Fluorouracil—stomach cancer	0.0157	0.0588	CbGbCtD
Rosiglitazone—ALB—Methotrexate—stomach cancer	0.0144	0.0542	CbGbCtD
Rosiglitazone—CYP2C9—Fluorouracil—stomach cancer	0.0141	0.053	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—stomach cancer	0.00735	0.0276	CbGbCtD
Rosiglitazone—PPARG—Topotecan—Irinotecan—stomach cancer	0.0028	1	CbGdCrCtD
Rosiglitazone—ACSL4—hematopoietic system—stomach cancer	0.00213	0.0598	CbGeAlD
Rosiglitazone—PPARG—blood vessel—stomach cancer	0.0018	0.0506	CbGeAlD
Rosiglitazone—ACSL4—pancreas—stomach cancer	0.00174	0.0487	CbGeAlD
Rosiglitazone—ALB—gall bladder—stomach cancer	0.00159	0.0446	CbGeAlD
Rosiglitazone—Pioglitazone—PPARG—stomach cancer	0.00155	1	CrCbGaD
Rosiglitazone—ACSL4—digestive system—stomach cancer	0.00148	0.0416	CbGeAlD
Rosiglitazone—ACSL4—bone marrow—stomach cancer	0.00137	0.0384	CbGeAlD
Rosiglitazone—ACSL4—endocrine gland—stomach cancer	0.00123	0.0344	CbGeAlD
Rosiglitazone—SLCO1B1—hematopoietic system—stomach cancer	0.00111	0.0312	CbGeAlD
Rosiglitazone—ACSL4—liver—stomach cancer	0.0011	0.031	CbGeAlD
Rosiglitazone—PTGS1—blood vessel—stomach cancer	0.000963	0.027	CbGeAlD
Rosiglitazone—PPARG—hematopoietic system—stomach cancer	0.000959	0.0269	CbGeAlD
Rosiglitazone—PPARG—epithelium—stomach cancer	0.000877	0.0246	CbGeAlD
Rosiglitazone—ACSL4—lymph node—stomach cancer	0.000847	0.0238	CbGeAlD
Rosiglitazone—PPARG—smooth muscle tissue—stomach cancer	0.000845	0.0237	CbGeAlD
Rosiglitazone—PPARG—pancreas—stomach cancer	0.000781	0.0219	CbGeAlD
Rosiglitazone—SLCO1B1—digestive system—stomach cancer	0.000773	0.0217	CbGeAlD
Rosiglitazone—CYP2C19—hematopoietic system—stomach cancer	0.000725	0.0203	CbGeAlD
Rosiglitazone—PPARG—lymphoid tissue—stomach cancer	0.000675	0.019	CbGeAlD
Rosiglitazone—PPARG—digestive system—stomach cancer	0.000667	0.0187	CbGeAlD
Rosiglitazone—SLCO1B1—endocrine gland—stomach cancer	0.000639	0.0179	CbGeAlD
Rosiglitazone—CYP2C8—hematopoietic system—stomach cancer	0.000632	0.0177	CbGeAlD
Rosiglitazone—PPARG—bone marrow—stomach cancer	0.000615	0.0173	CbGeAlD
Rosiglitazone—CYP1A2—hematopoietic system—stomach cancer	0.000592	0.0166	CbGeAlD
Rosiglitazone—CYP2A6—liver—stomach cancer	0.000584	0.0164	CbGeAlD
Rosiglitazone—SLCO1B1—liver—stomach cancer	0.000576	0.0162	CbGeAlD
Rosiglitazone—CYP2C9—hematopoietic system—stomach cancer	0.000562	0.0158	CbGeAlD
Rosiglitazone—PPARG—endocrine gland—stomach cancer	0.000551	0.0155	CbGeAlD
Rosiglitazone—PTGS1—hematopoietic system—stomach cancer	0.000513	0.0144	CbGeAlD
Rosiglitazone—CYP2C19—digestive system—stomach cancer	0.000504	0.0141	CbGeAlD
Rosiglitazone—PPARG—liver—stomach cancer	0.000497	0.0139	CbGeAlD
Rosiglitazone—PTGS1—epithelium—stomach cancer	0.000469	0.0132	CbGeAlD
Rosiglitazone—ALB—liver—stomach cancer	0.000466	0.0131	CbGeAlD
Rosiglitazone—PTGS1—smooth muscle tissue—stomach cancer	0.000452	0.0127	CbGeAlD
Rosiglitazone—CYP2D6—hematopoietic system—stomach cancer	0.000422	0.0118	CbGeAlD
Rosiglitazone—CYP2C19—endocrine gland—stomach cancer	0.000416	0.0117	CbGeAlD
Rosiglitazone—CYP1A2—digestive system—stomach cancer	0.000412	0.0116	CbGeAlD
Rosiglitazone—CYP2C9—digestive system—stomach cancer	0.000391	0.011	CbGeAlD
Rosiglitazone—PPARG—lymph node—stomach cancer	0.000381	0.0107	CbGeAlD
Rosiglitazone—CYP2C19—liver—stomach cancer	0.000375	0.0105	CbGeAlD
Rosiglitazone—CYP2C8—endocrine gland—stomach cancer	0.000363	0.0102	CbGeAlD
Rosiglitazone—ALB—lymph node—stomach cancer	0.000357	0.01	CbGeAlD
Rosiglitazone—PTGS1—digestive system—stomach cancer	0.000357	0.01	CbGeAlD
Rosiglitazone—CYP1A2—endocrine gland—stomach cancer	0.00034	0.00954	CbGeAlD
Rosiglitazone—CYP2C8—liver—stomach cancer	0.000328	0.0092	CbGeAlD
Rosiglitazone—Connective tissue disorder—Irinotecan—stomach cancer	0.000327	0.00376	CcSEcCtD
Rosiglitazone—Nausea—Mitomycin—stomach cancer	0.000323	0.00372	CcSEcCtD
Rosiglitazone—CYP2C9—endocrine gland—stomach cancer	0.000323	0.00906	CbGeAlD
Rosiglitazone—Hyperbilirubinaemia—Doxorubicin—stomach cancer	0.000314	0.00362	CcSEcCtD
Rosiglitazone—Cardiac disorder—Irinotecan—stomach cancer	0.000308	0.00355	CcSEcCtD
Rosiglitazone—CYP1A2—liver—stomach cancer	0.000307	0.0086	CbGeAlD
Rosiglitazone—Immune system disorder—Irinotecan—stomach cancer	0.0003	0.00346	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Docetaxel—stomach cancer	0.000297	0.00342	CcSEcCtD
Rosiglitazone—PTGS1—endocrine gland—stomach cancer	0.000295	0.00827	CbGeAlD
Rosiglitazone—Pulmonary oedema—Methotrexate—stomach cancer	0.000294	0.00338	CcSEcCtD
Rosiglitazone—CYP2D6—digestive system—stomach cancer	0.000293	0.00823	CbGeAlD
Rosiglitazone—Fluid retention—Epirubicin—stomach cancer	0.000293	0.00338	CcSEcCtD
Rosiglitazone—CYP2C9—liver—stomach cancer	0.000291	0.00817	CbGeAlD
Rosiglitazone—Nasopharyngitis—Capecitabine—stomach cancer	0.000288	0.00331	CcSEcCtD
Rosiglitazone—Back pain—Irinotecan—stomach cancer	0.00028	0.00322	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Methotrexate—stomach cancer	0.000275	0.00317	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Epirubicin—stomach cancer	0.000275	0.00317	CcSEcCtD
Rosiglitazone—Fluid retention—Doxorubicin—stomach cancer	0.000271	0.00312	CcSEcCtD
Rosiglitazone—Anaemia—Irinotecan—stomach cancer	0.000267	0.00308	CcSEcCtD
Rosiglitazone—Hepatic failure—Methotrexate—stomach cancer	0.000266	0.00307	CcSEcCtD
Rosiglitazone—Weight increased—Docetaxel—stomach cancer	0.000261	0.00301	CcSEcCtD
Rosiglitazone—Leukopenia—Irinotecan—stomach cancer	0.000259	0.00298	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000258	0.00298	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Epirubicin—stomach cancer	0.000258	0.00297	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Epirubicin—stomach cancer	0.000256	0.00295	CcSEcCtD
Rosiglitazone—Anaemia—Fluorouracil—stomach cancer	0.000256	0.00295	CcSEcCtD
Rosiglitazone—Pulmonary oedema—Doxorubicin—stomach cancer	0.000254	0.00293	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Docetaxel—stomach cancer	0.000254	0.00292	CcSEcCtD
Rosiglitazone—Weight increased—Capecitabine—stomach cancer	0.000253	0.00291	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Docetaxel—stomach cancer	0.000252	0.00291	CcSEcCtD
Rosiglitazone—Myocardial infarction—Docetaxel—stomach cancer	0.000251	0.00289	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Capecitabine—stomach cancer	0.000251	0.00289	CcSEcCtD
Rosiglitazone—Hypertension—Irinotecan—stomach cancer	0.00025	0.00288	CcSEcCtD
Rosiglitazone—Hepatic failure—Epirubicin—stomach cancer	0.000249	0.00287	CcSEcCtD
Rosiglitazone—Leukopenia—Fluorouracil—stomach cancer	0.000248	0.00286	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Epirubicin—stomach cancer	0.000247	0.00285	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Capecitabine—stomach cancer	0.000246	0.00283	CcSEcCtD
Rosiglitazone—Acute coronary syndrome—Capecitabine—stomach cancer	0.000244	0.00281	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Methotrexate—stomach cancer	0.000244	0.00281	CcSEcCtD
Rosiglitazone—Myocardial infarction—Capecitabine—stomach cancer	0.000243	0.0028	CcSEcCtD
Rosiglitazone—CYP2D6—endocrine gland—stomach cancer	0.000242	0.0068	CbGeAlD
Rosiglitazone—Hepatobiliary disease—Docetaxel—stomach cancer	0.000242	0.00279	CcSEcCtD
Rosiglitazone—Increased appetite—Epirubicin—stomach cancer	0.000238	0.00275	CcSEcCtD
Rosiglitazone—Diabetes mellitus—Doxorubicin—stomach cancer	0.000238	0.00275	CcSEcCtD
Rosiglitazone—Hepatic function abnormal—Doxorubicin—stomach cancer	0.000237	0.00273	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Irinotecan—stomach cancer	0.000236	0.00272	CcSEcCtD
Rosiglitazone—Oedema—Irinotecan—stomach cancer	0.000236	0.00272	CcSEcCtD
Rosiglitazone—Myalgia—Fluorouracil—stomach cancer	0.000236	0.00272	CcSEcCtD
Rosiglitazone—Infection—Irinotecan—stomach cancer	0.000235	0.0027	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Capecitabine—stomach cancer	0.000234	0.0027	CcSEcCtD
Rosiglitazone—Nervous system disorder—Irinotecan—stomach cancer	0.000232	0.00267	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Irinotecan—stomach cancer	0.000231	0.00266	CcSEcCtD
Rosiglitazone—Hepatic failure—Doxorubicin—stomach cancer	0.000231	0.00266	CcSEcCtD
Rosiglitazone—Hepatitis—Docetaxel—stomach cancer	0.00023	0.00265	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Epirubicin—stomach cancer	0.00023	0.00264	CcSEcCtD
Rosiglitazone—Cardiac failure—Epirubicin—stomach cancer	0.00023	0.00264	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Epirubicin—stomach cancer	0.000229	0.00263	CcSEcCtD
Rosiglitazone—Cardiac failure congestive—Doxorubicin—stomach cancer	0.000229	0.00263	CcSEcCtD
Rosiglitazone—Oedema peripheral—Docetaxel—stomach cancer	0.000226	0.00261	CcSEcCtD
Rosiglitazone—Oedema—Fluorouracil—stomach cancer	0.000226	0.00261	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Fluorouracil—stomach cancer	0.000226	0.00261	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Docetaxel—stomach cancer	0.000226	0.0026	CcSEcCtD
Rosiglitazone—Infection—Fluorouracil—stomach cancer	0.000225	0.00259	CcSEcCtD
Rosiglitazone—Hepatitis—Capecitabine—stomach cancer	0.000222	0.00256	CcSEcCtD
Rosiglitazone—Nervous system disorder—Fluorouracil—stomach cancer	0.000222	0.00256	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Fluorouracil—stomach cancer	0.000221	0.00255	CcSEcCtD
Rosiglitazone—Increased appetite—Doxorubicin—stomach cancer	0.000221	0.00254	CcSEcCtD
Rosiglitazone—Oedema peripheral—Capecitabine—stomach cancer	0.000219	0.00253	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Capecitabine—stomach cancer	0.000219	0.00252	CcSEcCtD
Rosiglitazone—CYP2D6—liver—stomach cancer	0.000218	0.00613	CbGeAlD
Rosiglitazone—Erythema multiforme—Docetaxel—stomach cancer	0.000217	0.0025	CcSEcCtD
Rosiglitazone—Eye disorder—Docetaxel—stomach cancer	0.000215	0.00247	CcSEcCtD
Rosiglitazone—Cardiac disorder—Docetaxel—stomach cancer	0.000213	0.00246	CcSEcCtD
Rosiglitazone—Hypoglycaemia—Doxorubicin—stomach cancer	0.000212	0.00245	CcSEcCtD
Rosiglitazone—Cardiac failure—Doxorubicin—stomach cancer	0.000212	0.00245	CcSEcCtD
Rosiglitazone—Cerebrovascular accident—Doxorubicin—stomach cancer	0.000212	0.00244	CcSEcCtD
Rosiglitazone—Erythema multiforme—Capecitabine—stomach cancer	0.00021	0.00242	CcSEcCtD
Rosiglitazone—Eye disorder—Capecitabine—stomach cancer	0.000208	0.0024	CcSEcCtD
Rosiglitazone—Immune system disorder—Docetaxel—stomach cancer	0.000208	0.00239	CcSEcCtD
Rosiglitazone—Cardiac disorder—Capecitabine—stomach cancer	0.000206	0.00238	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000206	0.00237	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000204	0.00235	CcSEcCtD
Rosiglitazone—PTGS1—lymph node—stomach cancer	0.000204	0.00572	CbGeAlD
Rosiglitazone—Fatigue—Irinotecan—stomach cancer	0.000204	0.00235	CcSEcCtD
Rosiglitazone—Constipation—Irinotecan—stomach cancer	0.000202	0.00233	CcSEcCtD
Rosiglitazone—Immune system disorder—Capecitabine—stomach cancer	0.000201	0.00232	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Epirubicin—stomach cancer	0.0002	0.00231	CcSEcCtD
Rosiglitazone—Malnutrition—Docetaxel—stomach cancer	0.0002	0.0023	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000195	0.00225	CcSEcCtD
Rosiglitazone—Malnutrition—Capecitabine—stomach cancer	0.000194	0.00223	CcSEcCtD
Rosiglitazone—Back pain—Docetaxel—stomach cancer	0.000193	0.00223	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000192	0.00222	CcSEcCtD
Rosiglitazone—Back pain—Capecitabine—stomach cancer	0.000187	0.00216	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—stomach cancer	0.000185	0.00214	CcSEcCtD
Rosiglitazone—Anaemia—Docetaxel—stomach cancer	0.000185	0.00213	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—stomach cancer	0.000183	0.00211	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Epirubicin—stomach cancer	0.00018	0.00207	CcSEcCtD
Rosiglitazone—Urticaria—Fluorouracil—stomach cancer	0.00018	0.00207	CcSEcCtD
Rosiglitazone—Leukopenia—Docetaxel—stomach cancer	0.000179	0.00206	CcSEcCtD
Rosiglitazone—Anaemia—Capecitabine—stomach cancer	0.000179	0.00206	CcSEcCtD
Rosiglitazone—Weight increased—Epirubicin—stomach cancer	0.000176	0.00203	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Epirubicin—stomach cancer	0.000175	0.00201	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—stomach cancer	0.000174	0.00201	CcSEcCtD
Rosiglitazone—Leukopenia—Capecitabine—stomach cancer	0.000173	0.002	CcSEcCtD
Rosiglitazone—Hypertension—Docetaxel—stomach cancer	0.000173	0.00199	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—stomach cancer	0.000171	0.00197	CcSEcCtD
Rosiglitazone—Arthralgia—Docetaxel—stomach cancer	0.00017	0.00196	CcSEcCtD
Rosiglitazone—Myalgia—Docetaxel—stomach cancer	0.00017	0.00196	CcSEcCtD
Rosiglitazone—Asthenia—Irinotecan—stomach cancer	0.000169	0.00195	CcSEcCtD
Rosiglitazone—Hypertension—Capecitabine—stomach cancer	0.000167	0.00193	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000166	0.00192	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—stomach cancer	0.000166	0.00191	CcSEcCtD
Rosiglitazone—Arthralgia—Capecitabine—stomach cancer	0.000165	0.0019	CcSEcCtD
Rosiglitazone—Myalgia—Capecitabine—stomach cancer	0.000165	0.0019	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Epirubicin—stomach cancer	0.000163	0.00188	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Docetaxel—stomach cancer	0.000163	0.00188	CcSEcCtD
Rosiglitazone—Oedema—Docetaxel—stomach cancer	0.000163	0.00188	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—stomach cancer	0.000163	0.00188	CcSEcCtD
Rosiglitazone—Infection—Docetaxel—stomach cancer	0.000162	0.00187	CcSEcCtD
Rosiglitazone—Sinusitis—Epirubicin—stomach cancer	0.000162	0.00187	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—stomach cancer	0.000162	0.00186	CcSEcCtD
Rosiglitazone—Diarrhoea—Irinotecan—stomach cancer	0.000162	0.00186	CcSEcCtD
Rosiglitazone—Nervous system disorder—Docetaxel—stomach cancer	0.00016	0.00184	CcSEcCtD
Rosiglitazone—Pruritus—Fluorouracil—stomach cancer	0.00016	0.00184	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Docetaxel—stomach cancer	0.00016	0.00184	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—stomach cancer	0.000158	0.00182	CcSEcCtD
Rosiglitazone—Oedema—Capecitabine—stomach cancer	0.000158	0.00182	CcSEcCtD
Rosiglitazone—Infection—Capecitabine—stomach cancer	0.000157	0.00181	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—stomach cancer	0.000157	0.0018	CcSEcCtD
Rosiglitazone—Dizziness—Irinotecan—stomach cancer	0.000156	0.0018	CcSEcCtD
Rosiglitazone—Nervous system disorder—Capecitabine—stomach cancer	0.000155	0.00179	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—stomach cancer	0.000155	0.00179	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—stomach cancer	0.000155	0.00178	CcSEcCtD
Rosiglitazone—Diarrhoea—Fluorouracil—stomach cancer	0.000155	0.00178	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Capecitabine—stomach cancer	0.000155	0.00178	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—stomach cancer	0.000154	0.00177	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—stomach cancer	0.000153	0.00176	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Epirubicin—stomach cancer	0.000152	0.00175	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000151	0.00174	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—stomach cancer	0.00015	0.00173	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—stomach cancer	0.00015	0.00172	CcSEcCtD
Rosiglitazone—Dizziness—Fluorouracil—stomach cancer	0.00015	0.00172	CcSEcCtD
Rosiglitazone—Rash—Irinotecan—stomach cancer	0.000149	0.00172	CcSEcCtD
Rosiglitazone—Dermatitis—Irinotecan—stomach cancer	0.000149	0.00171	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000149	0.00171	CcSEcCtD
Rosiglitazone—Headache—Irinotecan—stomach cancer	0.000148	0.0017	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—stomach cancer	0.000147	0.00169	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—stomach cancer	0.000145	0.00167	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—stomach cancer	0.000144	0.00166	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000144	0.00166	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—stomach cancer	0.000144	0.00166	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—stomach cancer	0.000143	0.00165	CcSEcCtD
Rosiglitazone—Rash—Fluorouracil—stomach cancer	0.000143	0.00164	CcSEcCtD
Rosiglitazone—Dermatitis—Fluorouracil—stomach cancer	0.000142	0.00164	CcSEcCtD
Rosiglitazone—Headache—Fluorouracil—stomach cancer	0.000142	0.00163	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—stomach cancer	0.000141	0.00163	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000141	0.00162	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—stomach cancer	0.000141	0.00162	CcSEcCtD
Rosiglitazone—Fatigue—Docetaxel—stomach cancer	0.000141	0.00162	CcSEcCtD
Rosiglitazone—Nausea—Irinotecan—stomach cancer	0.00014	0.00162	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—stomach cancer	0.00014	0.00161	CcSEcCtD
Rosiglitazone—Constipation—Docetaxel—stomach cancer	0.00014	0.00161	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—stomach cancer	0.000139	0.00161	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000136	0.00157	CcSEcCtD
Rosiglitazone—Fatigue—Capecitabine—stomach cancer	0.000136	0.00157	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—stomach cancer	0.000136	0.00156	CcSEcCtD
Rosiglitazone—Constipation—Capecitabine—stomach cancer	0.000135	0.00156	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—stomach cancer	0.000135	0.00155	CcSEcCtD
Rosiglitazone—Nausea—Fluorouracil—stomach cancer	0.000134	0.00155	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—stomach cancer	0.000134	0.00154	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—stomach cancer	0.000133	0.00154	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—stomach cancer	0.000133	0.00153	CcSEcCtD
Rosiglitazone—Back pain—Epirubicin—stomach cancer	0.00013	0.0015	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—stomach cancer	0.00013	0.00149	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—stomach cancer	0.000129	0.00149	CcSEcCtD
Rosiglitazone—Urticaria—Capecitabine—stomach cancer	0.000126	0.00145	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—stomach cancer	0.000125	0.00144	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—stomach cancer	0.000125	0.00144	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—stomach cancer	0.000123	0.00141	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—stomach cancer	0.000123	0.00141	CcSEcCtD
Rosiglitazone—Leukopenia—Epirubicin—stomach cancer	0.000121	0.00139	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—stomach cancer	0.000121	0.00139	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—stomach cancer	0.000118	0.00136	CcSEcCtD
Rosiglitazone—Asthenia—Docetaxel—stomach cancer	0.000117	0.00135	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—stomach cancer	0.000117	0.00135	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—stomach cancer	0.000116	0.00134	CcSEcCtD
Rosiglitazone—Pruritus—Docetaxel—stomach cancer	0.000115	0.00133	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—stomach cancer	0.000115	0.00133	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—stomach cancer	0.000115	0.00133	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—stomach cancer	0.000115	0.00133	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—stomach cancer	0.000115	0.00132	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—stomach cancer	0.000115	0.00132	CcSEcCtD
Rosiglitazone—Asthenia—Capecitabine—stomach cancer	0.000113	0.00131	CcSEcCtD
Rosiglitazone—Pruritus—Capecitabine—stomach cancer	0.000112	0.00129	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—stomach cancer	0.000112	0.00129	CcSEcCtD
Rosiglitazone—Diarrhoea—Docetaxel—stomach cancer	0.000112	0.00129	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—stomach cancer	0.00011	0.00127	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—stomach cancer	0.00011	0.00127	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—stomach cancer	0.000109	0.00126	CcSEcCtD
Rosiglitazone—Diarrhoea—Capecitabine—stomach cancer	0.000108	0.00125	CcSEcCtD
Rosiglitazone—Nervous system disorder—Epirubicin—stomach cancer	0.000108	0.00124	CcSEcCtD
Rosiglitazone—Dizziness—Docetaxel—stomach cancer	0.000108	0.00124	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—stomach cancer	0.000108	0.00124	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—stomach cancer	0.000108	0.00124	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000107	0.00124	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—stomach cancer	0.000106	0.00122	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—stomach cancer	0.000106	0.00122	CcSEcCtD
Rosiglitazone—Dizziness—Capecitabine—stomach cancer	0.000105	0.0012	CcSEcCtD
Rosiglitazone—Rash—Docetaxel—stomach cancer	0.000103	0.00119	CcSEcCtD
Rosiglitazone—Dermatitis—Docetaxel—stomach cancer	0.000103	0.00118	CcSEcCtD
Rosiglitazone—Headache—Docetaxel—stomach cancer	0.000102	0.00118	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—stomach cancer	0.000102	0.00117	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—stomach cancer	0.000102	0.00117	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000102	0.00117	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—stomach cancer	0.000101	0.00117	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—stomach cancer	0.000101	0.00117	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.0001	0.00116	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—stomach cancer	9.99e-05	0.00115	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—stomach cancer	9.97e-05	0.00115	CcSEcCtD
Rosiglitazone—Rash—Capecitabine—stomach cancer	9.96e-05	0.00115	CcSEcCtD
Rosiglitazone—Dermatitis—Capecitabine—stomach cancer	9.95e-05	0.00115	CcSEcCtD
Rosiglitazone—Headache—Capecitabine—stomach cancer	9.9e-05	0.00114	CcSEcCtD
Rosiglitazone—Nausea—Docetaxel—stomach cancer	9.7e-05	0.00112	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—stomach cancer	9.5e-05	0.0011	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—stomach cancer	9.49e-05	0.00109	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—stomach cancer	9.41e-05	0.00108	CcSEcCtD
Rosiglitazone—Nausea—Capecitabine—stomach cancer	9.39e-05	0.00108	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—stomach cancer	9.35e-05	0.00108	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	9.28e-05	0.00107	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—stomach cancer	8.79e-05	0.00101	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—stomach cancer	8.78e-05	0.00101	CcSEcCtD
Rosiglitazone—Urticaria—Epirubicin—stomach cancer	8.75e-05	0.00101	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—stomach cancer	8.71e-05	0.001	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—stomach cancer	8.44e-05	0.000973	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—stomach cancer	8.32e-05	0.000959	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—stomach cancer	8.09e-05	0.000933	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—stomach cancer	8.05e-05	0.000928	CcSEcCtD
Rosiglitazone—Asthenia—Epirubicin—stomach cancer	7.9e-05	0.00091	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—stomach cancer	7.79e-05	0.000898	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—stomach cancer	7.78e-05	0.000896	CcSEcCtD
Rosiglitazone—Diarrhoea—Epirubicin—stomach cancer	7.53e-05	0.000868	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—stomach cancer	7.42e-05	0.000855	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—stomach cancer	7.41e-05	0.000854	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—stomach cancer	7.37e-05	0.000849	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—stomach cancer	7.31e-05	0.000842	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—stomach cancer	7.28e-05	0.000839	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—stomach cancer	7.21e-05	0.00083	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—stomach cancer	6.99e-05	0.000805	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—stomach cancer	6.97e-05	0.000803	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—stomach cancer	6.94e-05	0.0008	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—stomach cancer	6.94e-05	0.000799	CcSEcCtD
Rosiglitazone—Headache—Epirubicin—stomach cancer	6.9e-05	0.000795	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—stomach cancer	6.74e-05	0.000776	CcSEcCtD
Rosiglitazone—Nausea—Epirubicin—stomach cancer	6.54e-05	0.000754	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—stomach cancer	6.42e-05	0.00074	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—stomach cancer	6.42e-05	0.000739	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—stomach cancer	6.38e-05	0.000735	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—stomach cancer	6.05e-05	0.000697	CcSEcCtD
Rosiglitazone—CYP2C9—Metabolism—ECHS1—stomach cancer	1e-05	0.000142	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPP2R1A—stomach cancer	1e-05	0.000141	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ALDOB—stomach cancer	1e-05	0.000141	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CD44—stomach cancer	9.9e-06	0.00014	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PRKCB—stomach cancer	9.86e-06	0.000139	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—MAPK1—stomach cancer	9.85e-06	0.000139	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTP1—stomach cancer	9.81e-06	0.000138	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—SREBF2—stomach cancer	9.69e-06	0.000137	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—HMOX1—stomach cancer	9.68e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLCE1—stomach cancer	9.63e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDH7A1—stomach cancer	9.63e-06	0.000136	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—RORA—stomach cancer	9.58e-06	0.000135	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMP—stomach cancer	9.52e-06	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—FADS1—stomach cancer	9.52e-06	0.000134	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—SERPINE1—stomach cancer	9.51e-06	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.48e-06	0.000134	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.46e-06	0.000133	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMP—stomach cancer	9.44e-06	0.000133	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—FADS1—stomach cancer	9.44e-06	0.000133	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	9.43e-06	0.000133	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	9.41e-06	0.000133	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALOX5—stomach cancer	9.35e-06	0.000132	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—CAV1—stomach cancer	9.33e-06	0.000132	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—APOA1—stomach cancer	9.31e-06	0.000131	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ALOX5—stomach cancer	9.3e-06	0.000131	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—HRAS—stomach cancer	9.24e-06	0.00013	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—UMPS—stomach cancer	9.23e-06	0.00013	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—DPYD—stomach cancer	9.2e-06	0.00013	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—DPYD—stomach cancer	9.15e-06	0.000129	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—TYMS—stomach cancer	9.12e-06	0.000129	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—GSTM1—stomach cancer	9.02e-06	0.000127	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALDOB—stomach cancer	8.98e-06	0.000127	CbGpPWpGaD
Rosiglitazone—ALB—Transmembrane transport of small molecules—APOA1—stomach cancer	8.95e-06	0.000126	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	8.92e-06	0.000126	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SREBF2—stomach cancer	8.92e-06	0.000126	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPP2R1A—stomach cancer	8.9e-06	0.000126	CbGpPWpGaD
Rosiglitazone—PPARG—Developmental Biology—IL6—stomach cancer	8.84e-06	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SREBF2—stomach cancer	8.84e-06	0.000125	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—RORA—stomach cancer	8.81e-06	0.000124	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—RORA—stomach cancer	8.74e-06	0.000123	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTP1—stomach cancer	8.73e-06	0.000123	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—HMOX1—stomach cancer	8.61e-06	0.000121	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PDHA1—stomach cancer	8.58e-06	0.000121	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ECHS1—stomach cancer	8.58e-06	0.000121	CbGpPWpGaD
Rosiglitazone—ALB—Platelet activation, signaling and aggregation—PIK3CA—stomach cancer	8.55e-06	0.000121	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ERCC2—stomach cancer	8.48e-06	0.00012	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	8.46e-06	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	8.45e-06	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPP2R1A—stomach cancer	8.41e-06	0.000119	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALOX5—stomach cancer	8.35e-06	0.000118	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.34e-06	0.000118	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	8.29e-06	0.000117	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALDOB—stomach cancer	8.26e-06	0.000116	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTP1—stomach cancer	8.25e-06	0.000116	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—DPYD—stomach cancer	8.21e-06	0.000116	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SERPINE1—stomach cancer	8.2e-06	0.000116	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALDOB—stomach cancer	8.19e-06	0.000115	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—HMOX1—stomach cancer	8.14e-06	0.000115	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTT1—stomach cancer	8.13e-06	0.000115	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—TYMS—stomach cancer	8.11e-06	0.000114	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTT1—stomach cancer	8.09e-06	0.000114	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMP—stomach cancer	8.07e-06	0.000114	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FADS1—stomach cancer	8.07e-06	0.000114	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP2A6—stomach cancer	8.04e-06	0.000113	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—GSTM1—stomach cancer	8.02e-06	0.000113	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP2A6—stomach cancer	7.99e-06	0.000113	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—MTHFR—stomach cancer	7.97e-06	0.000112	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—RHOA—stomach cancer	7.91e-06	0.000112	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—NOS3—stomach cancer	7.83e-06	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKR1C3—stomach cancer	7.82e-06	0.00011	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKR1C3—stomach cancer	7.78e-06	0.00011	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	7.72e-06	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	7.7e-06	0.000109	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALOX5—stomach cancer	7.68e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—TYMS—stomach cancer	7.67e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ENO1—stomach cancer	7.62e-06	0.000108	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALOX5—stomach cancer	7.61e-06	0.000107	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—GSTM1—stomach cancer	7.58e-06	0.000107	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ENO1—stomach cancer	7.58e-06	0.000107	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SREBF2—stomach cancer	7.55e-06	0.000107	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—DPYD—stomach cancer	7.55e-06	0.000107	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ERCC2—stomach cancer	7.54e-06	0.000106	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—ALB—stomach cancer	7.5e-06	0.000106	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—DPYD—stomach cancer	7.49e-06	0.000106	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—RORA—stomach cancer	7.46e-06	0.000105	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	7.44e-06	0.000105	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—ALB—stomach cancer	7.38e-06	0.000104	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—CAV1—stomach cancer	7.35e-06	0.000104	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—APOA1—stomach cancer	7.33e-06	0.000103	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTT1—stomach cancer	7.26e-06	0.000102	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP2A6—stomach cancer	7.18e-06	0.000101	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ERCC2—stomach cancer	7.13e-06	0.000101	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—MTHFR—stomach cancer	7.09e-06	0.0001	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—NOS3—stomach cancer	7.06e-06	9.96e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.02e-06	9.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALDOB—stomach cancer	6.99e-06	9.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKR1C3—stomach cancer	6.98e-06	9.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ENO1—stomach cancer	6.8e-06	9.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	6.79e-06	9.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CD44—stomach cancer	6.76e-06	9.54e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CD44—stomach cancer	6.72e-06	9.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—MTHFR—stomach cancer	6.7e-06	9.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.69e-06	9.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTT1—stomach cancer	6.68e-06	9.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTT1—stomach cancer	6.62e-06	9.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP2A6—stomach cancer	6.6e-06	9.31e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	6.6e-06	9.3e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	6.58e-06	9.28e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.56e-06	9.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP2A6—stomach cancer	6.54e-06	9.23e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—CAV1—stomach cancer	6.54e-06	9.22e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—APOA1—stomach cancer	6.52e-06	9.2e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	6.52e-06	9.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALOX5—stomach cancer	6.5e-06	9.17e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PPARG—stomach cancer	6.46e-06	9.11e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTGS2—stomach cancer	6.46e-06	9.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKR1C3—stomach cancer	6.42e-06	9.06e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—DPYD—stomach cancer	6.4e-06	9.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKR1C3—stomach cancer	6.37e-06	8.98e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ENO1—stomach cancer	6.26e-06	8.83e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	6.25e-06	8.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ENO1—stomach cancer	6.2e-06	8.75e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MAPK3—stomach cancer	6.19e-06	8.73e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—CAV1—stomach cancer	6.18e-06	8.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—APOA1—stomach cancer	6.17e-06	8.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—ALB—stomach cancer	6.1e-06	8.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CD44—stomach cancer	6.03e-06	8.51e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—stomach cancer	6.02e-06	8.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.85e-06	8.26e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—stomach cancer	5.81e-06	8.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	5.8e-06	8.18e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PPARG—stomach cancer	5.75e-06	8.11e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPP2R1A—stomach cancer	5.75e-06	8.11e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPP2R1A—stomach cancer	5.72e-06	8.06e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—stomach cancer	5.66e-06	7.98e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—stomach cancer	5.64e-06	7.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—stomach cancer	5.64e-06	7.95e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—stomach cancer	5.61e-06	7.91e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2A6—stomach cancer	5.59e-06	7.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—stomach cancer	5.56e-06	7.84e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—stomach cancer	5.56e-06	7.84e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CD44—stomach cancer	5.55e-06	7.83e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—stomach cancer	5.53e-06	7.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CD44—stomach cancer	5.5e-06	7.76e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKR1C3—stomach cancer	5.44e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PPARG—stomach cancer	5.44e-06	7.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	5.34e-06	7.53e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK3—stomach cancer	5.34e-06	7.53e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO1—stomach cancer	5.3e-06	7.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TYMS—stomach cancer	5.24e-06	7.39e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	5.21e-06	7.35e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TYMS—stomach cancer	5.21e-06	7.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—stomach cancer	5.18e-06	7.31e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—stomach cancer	5.17e-06	7.29e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—stomach cancer	5.15e-06	7.27e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPP2R1A—stomach cancer	5.13e-06	7.24e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—stomach cancer	5.08e-06	7.17e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK1—stomach cancer	5.08e-06	7.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—stomach cancer	5.03e-06	7.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—stomach cancer	4.96e-06	7e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—stomach cancer	4.94e-06	6.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—stomach cancer	4.89e-06	6.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ERCC2—stomach cancer	4.87e-06	6.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ERCC2—stomach cancer	4.84e-06	6.83e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—stomach cancer	4.8e-06	6.77e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPP2R1A—stomach cancer	4.72e-06	6.66e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CD44—stomach cancer	4.7e-06	6.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TYMS—stomach cancer	4.68e-06	6.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPP2R1A—stomach cancer	4.68e-06	6.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—stomach cancer	4.68e-06	6.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—stomach cancer	4.63e-06	6.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—stomach cancer	4.62e-06	6.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—stomach cancer	4.59e-06	6.47e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—stomach cancer	4.58e-06	6.46e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—stomach cancer	4.56e-06	6.44e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	4.56e-06	6.43e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—stomach cancer	4.55e-06	6.42e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—stomach cancer	4.53e-06	6.38e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—stomach cancer	4.52e-06	6.38e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—stomach cancer	4.41e-06	6.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ERCC2—stomach cancer	4.35e-06	6.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMS—stomach cancer	4.3e-06	6.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—stomach cancer	4.28e-06	6.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMS—stomach cancer	4.27e-06	6.02e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—stomach cancer	4.26e-06	6.01e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—stomach cancer	4.25e-06	6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAV1—stomach cancer	4.22e-06	5.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—stomach cancer	4.22e-06	5.95e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—APOA1—stomach cancer	4.21e-06	5.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAV1—stomach cancer	4.2e-06	5.92e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—APOA1—stomach cancer	4.19e-06	5.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—stomach cancer	4.09e-06	5.76e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—stomach cancer	4.08e-06	5.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.04e-06	5.69e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	4.01e-06	5.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ERCC2—stomach cancer	4e-06	5.64e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPP2R1A—stomach cancer	4e-06	5.64e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—stomach cancer	3.97e-06	5.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ERCC2—stomach cancer	3.96e-06	5.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—stomach cancer	3.92e-06	5.53e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—stomach cancer	3.87e-06	5.45e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAV1—stomach cancer	3.77e-06	5.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—APOA1—stomach cancer	3.76e-06	5.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—stomach cancer	3.76e-06	5.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—stomach cancer	3.73e-06	5.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PPARG—stomach cancer	3.71e-06	5.24e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PPARG—stomach cancer	3.69e-06	5.21e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMS—stomach cancer	3.65e-06	5.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—stomach cancer	3.6e-06	5.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.6e-06	5.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAV1—stomach cancer	3.47e-06	4.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—APOA1—stomach cancer	3.46e-06	4.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAV1—stomach cancer	3.44e-06	4.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—APOA1—stomach cancer	3.43e-06	4.84e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ERCC2—stomach cancer	3.39e-06	4.78e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—stomach cancer	3.34e-06	4.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PPARG—stomach cancer	3.31e-06	4.67e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	3.28e-06	4.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—stomach cancer	3.19e-06	4.5e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—stomach cancer	3.18e-06	4.49e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—stomach cancer	3.18e-06	4.48e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—stomach cancer	3.13e-06	4.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PPARG—stomach cancer	3.05e-06	4.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PPARG—stomach cancer	3.02e-06	4.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—stomach cancer	2.98e-06	4.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAV1—stomach cancer	2.94e-06	4.14e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—APOA1—stomach cancer	2.93e-06	4.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—stomach cancer	2.92e-06	4.12e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—stomach cancer	2.9e-06	4.1e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—stomach cancer	2.85e-06	4.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	2.81e-06	3.96e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—stomach cancer	2.78e-06	3.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—stomach cancer	2.74e-06	3.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—stomach cancer	2.72e-06	3.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—stomach cancer	2.63e-06	3.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—stomach cancer	2.62e-06	3.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—stomach cancer	2.61e-06	3.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—stomach cancer	2.6e-06	3.67e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PPARG—stomach cancer	2.58e-06	3.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—stomach cancer	2.4e-06	3.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—stomach cancer	2.38e-06	3.35e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—stomach cancer	2.32e-06	3.28e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—stomach cancer	2.22e-06	3.13e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—stomach cancer	2.03e-06	2.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—stomach cancer	1.8e-06	2.53e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—stomach cancer	1.79e-06	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—stomach cancer	1.6e-06	2.26e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—stomach cancer	1.48e-06	2.08e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—stomach cancer	1.46e-06	2.06e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—stomach cancer	1.25e-06	1.76e-05	CbGpPWpGaD
